Ophthal Medical News about Uveal Melanoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis
Ophthalmology, 09/11/09

Lane AM et al. – In multivariate Cox regression, IFN–alfa–2a had no significant influence on melanoma–related mortality or all–cause mortality. Interferon–alfa–2a has no material influence on survival in patients with choroidal melanoma.

<< Previous
Surgical Management of Childhood Intermittent Exotropia

Next >>
Prognostic Significance of Delayed Structural Recovery after...

A reappraisal of the significance of largest basal diameter of posterior uveal melanoma
Eye, 11/02/09 Relevance Score: 68%

Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease
Current Opinion in Ophthalmology, 10/27/09 Relevance Score: 67%

Surgical management of liver metastases from uveal melanoma: 16 years experience at the Institut Curie
European Journal of Surgical Oncology, 10/21/09 Relevance Score: 67%

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey
Investigative Ophthalmology and Visual Science, 10/15/09 Relevance Score: 67%

Molecular Prognostic Testing and Individualized Patient Care in Uveal Melanoma
American Journal of Ophthalmology, 10/06/09 Relevance Score: 67%